Latest filing published 28 Feb 2022 for TELA Bio, Inc., €10k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Ellis Skott Greenhalgh: trading record in brief
Ellis Skott Greenhalgh, listed as senior executive, appears in our data through filings on TELA Bio, Inc. shares, published by SEC (Form 4). In total, 6 filings cover trades dated from 13 November 2019 to 24 February 2022.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 28 February 2022: a share grant of €10k, in TELA Bio, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Ellis Skott Greenhalgh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 973 shares@ US$11.98100.0% of flowCommon StockSEC:0001062993-22-005910:0
- 3,900 shares0Common StockSEC:0001062993-22-005779:0
2 of 2 declarations
